🇺🇸 FDA
Pipeline program

Nizatidine

14-004137

Phase 1 small_molecule completed

Quick answer

Nizatidine for Gastroparesis is a Phase 1 program (small_molecule) at ADIAL PHARMACEUTICALS, INC. with 1 ClinicalTrials.gov record(s).

Program details

Company
ADIAL PHARMACEUTICALS, INC.
Indication
Gastroparesis
Phase
Phase 1
Modality
small_molecule
Status
completed

Clinical trials